Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 334-rectal-resection-without-cc-mcc
    Ask Trek AI about this page

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    DRG 334 encompasses inpatient rectal resection procedures without Complication or Comorbidity or Major Complication or Comorbidity, involving resections for neoplasm, inflammatory disease, or other localized rectal pathology. Correct grouping into this Diagnosis-Related Group is important because it establishes the Medicare payment category and reflects expected resource use for inpatient care.

    Customize your policy alerts

    Sign up for drg 334 policy alerts

    Get alerted when payer policies referencing 334 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 334 Overview

    DRG 334 covers inpatient hospitalizations for rectal resection procedures without the presence of Complication or Comorbidity or Major Complication or Comorbidity. This Diagnosis-Related Group typically includes elective and some urgent resections for rectal neoplasms, inflammatory conditions, or other localized disease processes requiring partial or total rectal resection. It matters for Centers for Medicare & Medicaid Services payment because classification into this Diagnosis-Related Group affects base payment rates and resource intensity for Medicare inpatient reimbursement. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and thus influence payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative enhanced recovery and morbidity reduction trials: randomized or pragmatic studies testing perioperative care bundles (multimodal analgesia, bowel prep strategies, minimally invasive approaches, and early mobilization) in patients undergoing elective or urgent rectal resection without CC/MCC. These studies enroll adult patients with rectal neoplasia or benign rectal disease who are otherwise not severely complicated, and they measure rates of surgical site infection, anastomotic leak, opioid consumption, length of stay, and readmission. Findings are relevant to surgeons and hospital administrators because improved perioperative protocols can reduce in-hospital complications and resource use, directly affecting short-term costs and DRG-based reimbursement performance.
    • Comparative effectiveness studies of operative technique and reconstruction: noninferiority or registry-based comparative studies examining open versus laparoscopic versus minimally invasive transanal approaches, and variations in anastomotic technique or diversion practices, among patients undergoing rectal resection without major comorbidities. These trials focus on operative time, conversion rates, functional outcomes (bowel control, sexual and urinary function), postoperative complications, and need for reintervention, enrolling typical DRG 334 patients treated at tertiary and community centers. Results inform clinicians and payers about which surgical strategies yield better clinical outcomes and lower downstream costs for this relatively lower-acuity cohort, guiding standards of care, contracting, and quality measurement.
    • Post-discharge recovery, quality of life, and resource utilization studies: prospective cohort or randomized studies testing interventions such as structured discharge pathways, remote monitoring, or rehabilitation programs to improve recovery and reduce readmissions in patients after rectal resection without CC/MCC. These studies target patients at discharge who are medically stable but at risk for issues such as dehydration, wound problems, or functional impairment, and they capture patient-reported outcomes, unplanned healthcare utilization, and total 30- to 90-day costs. For providers and payers managing DRG 334 admissions, evidence from these studies helps allocate transitional care resources effectively to lower readmission rates and overall episode costs while maintaining patient-centered outcomes.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    332-RECTAL-RESECTION-WITH-MCC

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    336-PERITONEAL-ADHESIOLYSIS-WITH-CC

    Peritoneal Adhesiolysis with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.